Who Is Most at Risk for B12 Deficiency
The Phase 2 trial reference point The Phase 2 retatrutide trial (Jastreboff et al., New England Journal of Medicine 2023) enrolled 338 adults across placebo and retatrutide arms at 1, 4, 8, and 12 mg weekly
This ensures that each treatment is both safe and effective, giving you peace of mind as you support your wellness
High doses are generally considered safe, though some people may experience minor side effects
Neurobion is formulated in two forms: coated tablets and injectable ampoules: Neurobion coated tablet form: The tablets are round, white, and bilayered, with each tablet containing 100 mg of Vitamin B1, 200 mg of Vitamin B6, and 200 mcg of Vitamin B12
However, FDA approval for the general population does not translate to automatic safety in every subgroup